TableĀ 4

Temporal trends for improvement among each category per year from 2003 to 2008

Risk StratumComposite of all guideline-directed medications at discharge
RR (95% CI)
Persistence with composite of all guideline-directed medications after discharge
RR (95% CI)
Low risk1.01 (1.00 to 1.02)1.02 (1.01 to 1.04)
Intermediate risk1.01 (0.99 to 1.02)1.03 (1.01 to 1.04)
High risk1.03 (1.01 to 1.05)1.05 (1.03 to 1.08)
  • All risk ratios >1 signify an increase in medication use over the duration of this study and risk ratios crossing 1 signify no statistically significant difference in medication use over the duration of this study.

  • RR, relative risk.